Westchester Capital Management (New York)’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-860,852
Closed -$9.33M – 334
2026
Q1
$9.33M Sell
860,852
-500,000
-37% -$5.38M 0.42% 47
2025
Q4
$14.6M Buy
1,360,852
+250,000
+23% +$2.67M 0.61% 29
2025
Q3
$11.8M Sell
1,110,852
-50,000
-4% -$529K 0.54% 40
2025
Q2
$12.2M Hold
1,160,852
– – 0.64% 32
2025
Q1
$12M Buy
1,160,852
+250,852
+28% +$2.57M 0.62% 31
2024
Q4
$9.23M Buy
910,000
+360,000
+65% +$3.64M 0.5% 38
2024
Q3
$5.53M Buy
+550,000
New +$5.51M 0.24% 56

Other funds holding GPAT

Westchester Capital Management (New York)'s GPAT Position: Q2 2026 in Review

Westchester Capital Management (New York) sold out of GP-Act III Acquisition Corp (GPAT) in Q2 2026, closing a stake of 860,852 shares — an estimated $9.33M sold.

Westchester Capital Management (New York) first reported a position in GPAT in Q3 2024 and held it in 7 quarters. The position peaked at $14.6M in Q4 2025. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • Westchester Capital Management (New York) reported no remaining GP-Act III Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 860,852 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $9.33M.
  • Westchester Capital Management (New York) first reported a position in GP-Act III Acquisition Corp in Q3 2024 and held it in 7 quarters.
  • Westchester Capital Management (New York)'s GP-Act III Acquisition Corp position peaked at $14.6M in Q4 2025.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.